MARKET

CNMD

CNMD

Conmed Corp
NYSE
80.08
-0.72
-0.89%
After Hours: 80.08 0 0.00% 16:01 02/26 EST
OPEN
80.29
PREV CLOSE
80.80
HIGH
81.05
LOW
79.15
VOLUME
421.00K
TURNOVER
0
52 WEEK HIGH
138.47
52 WEEK LOW
79.15
MARKET CAP
2.46B
P/E (TTM)
39.19
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CNMD last week (0219-0223)?
Weekly Report · 18h ago
Needham sees orthopedics market slowing; favors Enovis, Paragon 28
Healthcare Needham sees orthopedics market slowing; favors Enovis, Paragon 28. Needham says it expects growth in the orthopedic device market to slow to 4% to 5% for 2024 and beyond. The investment bank says it sees growth in 2023 at the highest rate in over ten years.
Seeking Alpha · 1d ago
Weekly Report: what happened at CNMD last week (0212-0216)?
Weekly Report · 02/19 09:25
Oversold Conditions For CONMED (CNMD)
NASDAQ · 02/16 22:40
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%
The CONMED Corporation (NYSE:CNMD) share price has fallen by 26% over the last month. The company's price-to-sales ratio of 2.1x is lower than most of its industry peers. The low P/S ratio could be an indication the company's revenue growth is being questioned. CONMED grew revenue by 19% last year and is expected to grow by 8.4% in the coming years.
Simply Wall St · 02/15 10:34
Weekly Report: what happened at CNMD last week (0205-0209)?
Weekly Report · 02/12 09:22
Weekly Report: what happened at CNMD last week (0129-0202)?
Weekly Report · 02/05 09:24
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results
CONMED Corporation (NYSE:CNMD) has dropped 12% in the week since its latest annual results. Revenues of US$1.2b were in line with forecasts, but statutory earnings per share missed estimates by 2.6%. The analysts are now forecasting 8.4% growth in revenue for the company in 2024. The analysts have also reduced their earnings forecasts for next year and cut their price targets. The stock is expected to fall 12% to US$80.91 following the latest results.
Simply Wall St · 02/03 12:54
More
About CNMD
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Webull offers Conmed Corp stock information, including NYSE: CNMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CNMD stock methods without spending real money on the virtual paper trading platform.